Laboratory Tests in the Diagnosis of the Chronic Pancreatic Diseases. Part 6. Differentiation Between Chronic Pancreatitis and Pancreatic Cancer

Overview

Journal Int J Pancreatol

Specialty Gastroenterology

Date 1988 May 1

PMID 3290345

Citations 2

Authors

E J Boyd

H Rinderknecht

K G Wormsley

Affiliations

Soon will be listed here.

Citing Articles

Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences.

Taylor B World J Surg. 2003; 27(11):1249-57.

PMID: 14502404 DOI: 10.1007/s00268-003-7245-8.

Diagnosing cancer of the pancreas.

Thompson J BMJ. 1990; 301(6755):775-6.

PMID: 2224261 PMC: 1663939. DOI: 10.1136/bmj.301.6755.775.

References

Mackie C, Dhorajiwala J, Blackstone M, Bowie J, Moossa A . Value of new diagnostic aids in relation to the disease process in pancreatic cancer. Lancet. 1979; 2(8139):385-9. DOI: 10.1016/s0140-6736(79)90403-3. View

Malesci A, Tommasini M, Bonato C, Bocchia P, Bersani M, Zerbi A . Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. Gastroenterology. 1987; 92(1):60-7. DOI: 10.1016/0016-5085(87)90840-7. View

Nishida K, Yoshikawa T, Kondo M, THIELE H . Immunological diagnosis of pancreatic cancer by assaying carcinoembryonic antigen (CEA) in pure pancreatic juice. Hepatogastroenterology. 1980; 27(6):488-94. View

Sakahara H, Endo K, Nakajima K, Nakashima T, Koizumi M, Ohta H . Serum CA 19-9 concentrations and computed tomography findings in patients with pancreatic carcinoma. Cancer. 1986; 57(7):1324-6. DOI: 10.1002/1097-0142(19860401)57:7<1324::aid-cncr2820570712>3.0.co;2-a. View

Panucci A, Fabris C, Del Favero G, Basso D, Di Mario F, Marchioro L . Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer?. J Clin Pathol. 1986; 39(1):75-7. PMC: 499616. DOI: 10.1136/jcp.39.1.75. View

DiMagno E, Malagelada J, MOERTEL C, Go V . Prospective evaluation of the pancreatic secretion of immunoreactive carcinoembryonic antigen, enzyme, and bicarbonate in patients suspected of having pancreatic cancer. Gastroenterology. 1977; 73(3):457-61. View

Farini R, Nitti D, Del Favero G, Rossi C, Costantin G, Rebuffi A . CEA concentration and cytology in duodenal fluid collected during the Secretin-Pancreozymin test. Attempt at an early diagnosis of pancreatic carcinoma by means of simple procedure. Hepatogastroenterology. 1980; 27(3):213-6. View

GOODALE R, GAJL-PECZALSKA K, Dressel T, Samuelson J . Cytologic studies for the diagnosis of pancreatic cancer. Cancer. 1981; 47(6 Suppl):1652-5. DOI: 10.1002/1097-0142(19810315)47:6+<1652::aid-cncr2820471432>3.0.co;2-f. View

Warshaw A, Lee K, Wood W, Cohen A . Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancer. Am J Surg. 1980; 139(1):27-32. DOI: 10.1016/0002-9610(80)90225-1. View

10.

Hunt D, Blumgart L . Preoperative differentiation between carcinoma of the pancreas and chronic pancreatitis: the contribution of cytology. Endoscopy. 1982; 14(5):171-3. DOI: 10.1055/s-2007-1021612. View

11.

Satake K, Chung Y, Umeyama K . Serum elastase I levels in pancreatic disease. Am J Surg. 1982; 144(2):239-42. DOI: 10.1016/0002-9610(82)90517-7. View

12.

Multigner L, FIGARELLA C, SARLES H . Diagnosis of chronic pancreatitis by measurement of lactoferrin in duodenal juice. Gut. 1981; 22(5):350-4. PMC: 1419249. DOI: 10.1136/gut.22.5.350. View

13.

Del Villano B, Brennan S, Brock P, Bucher C, Liu V, McClure M . Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem. 1983; 29(3):549-52. View

14.

Tatsuta M, Yamamura H, Noguchi S, Ichii M, Iishi H, Okuda S . Values of serum carcinoembryonic antigen and elastase 1 in diagnosis of pancreatic carcinoma. Gut. 1984; 25(12):1347-51. PMC: 1420216. DOI: 10.1136/gut.25.12.1347. View

15.

Haglund C, Roberts P, Kuusela P, Scheinin T, Makela O, Jalanko H . Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer. 1986; 53(2):197-202. PMC: 2001324. DOI: 10.1038/bjc.1986.35. View

16.

Safi F, Beger H, Bittner R, Buchler M, Krautzberger W . CA 19-9 and pancreatic adenocarcinoma. Cancer. 1986; 57(4):779-83. DOI: 10.1002/1097-0142(19860215)57:4<779::aid-cncr2820570417>3.0.co;2-c. View

17.

Mahvi D, Meyers W, Bast R, Seigler H, METZGAR R . Carcinoma of the pancreas. Therapeutic efficacy as defined by a serodiagnostic test utilizing a monoclonal antibody. Ann Surg. 1985; 202(4):440-5. PMC: 1250942. DOI: 10.1097/00000658-198510000-00005. View

18.

Habib N, Hershman M, Haberland F, Papp L, Wood C, Williamson R . The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. Br J Cancer. 1986; 53(5):697-9. PMC: 2001389. DOI: 10.1038/bjc.1986.116. View

19.

Wood R, Moossa A . The prospective evaluation of tumour-associated antigens for the early diagnosis of pancreatic cancer. Br J Surg. 1977; 64(10):718-20. DOI: 10.1002/bjs.1800641009. View

20.

Estevenon J, FIGARELLA C . A non competitive enzyme immunoassay of human lactoferrin in biological fluids. Clin Chim Acta. 1983; 129(3):311-8. DOI: 10.1016/0009-8981(83)90034-7. View